History of cervical cancer stage IIA. PELVIS:UTERUS, ADNEXA: Heterogeneous mildly T2-weighted hypointense cervical mass with peripheral cystic components and heterogeneous enhancement measuring up to 6.3 x 5.0 x 5.0 cm (series 801/28 and series 701/22). The lesion extends to and along the involved anterior superior half of the vaginal wall (series 701/22). The lesion extends into the parametrial soft tissues along the left posterolateral aspect involving the mesorectal fascia (series 801/29). There is no well-defined margin along the anterior aspect of the mass compatible with parametrial invasion.Lobular enlargement of the uterus secondary to numerous well-defined T1 and T2 hypointense masses compatible with fibroids some of which demonstrate minimal cystic changes. The uterus measures 21.5 x 8.5 cm in the sagittal plane.The endometrial cavity is distended up to 3.0 cm with nonenhancing dependent debris.BLADDER: No significant abnormality noted.LYMPH NODES: Prominent right pelvic sidewall lymph node measuring 1.9 x 0.8 cm (series 1601/254).BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
6.3 cm cervical mass with parametrial and soft tissue involvement as described above. Non-specific right pelvic side wall prominent lymph node.